Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung

Cost-effectiveness of epidermal growth factor receptor mutation testing and first-line treatment with gefitinib for patients with advanced adenocarcinoma of the lung

10.1002/cncr.26372

Saved in:
Bibliographic Details
Main Authors: De Lima Lopes Jr., G., Segel, J.E., Tan, D.S.W., Do, Y.K., Mok, T., Finkelstein, E.A.
Other Authors: DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format: Article
Published: 2016
Subjects:
Asia
cost-effectiveness
economic evaluation
epidermal growth factor receptor
gefitinib
lung adenocarcinoma
Online Access:http://scholarbank.nus.edu.sg/handle/10635/124662
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1002/cncr.26372

Similar Items